Biotechnology firm Leap Therapeutics (Nasdaq: LPTX) has secured a significant funding boost of $58.88 million through a private investment in public equity (PIPE) transaction, paving the way for […]
Biotech Stocks Dip Amid Shift in Bitcoin Strategy
New strategies for utilizing cryptocurrency are shaking up the biotech sector. BitMine and SharpLink, two prominent companies in this field, have made significant investments in Ethereum (ETH), which […]
BioNTech Acquires CureVac: mRNA Therapeutics Giant Takes Aim at Cancer Immunotherapy
German biotech firm BioNTech has acquired its competitor, CureVac, in a $1.25 billion all-stock deal. This strategic move combines two leaders in the mRNA therapeutics space and signals […]
Brian Armstrong Invests $130 Million in Anti-Aging Startup NewLimit
Coinbase CEO Brian Armstrong is taking on two major challenges: the complexities of human aging and the evolving landscape of cryptocurrency regulation. He’s tackling these issues head-on by […]
NewLimit Secures $130 Million to Drive Age-Reversal Research
Biotech firm NewLimit, co-founded by Coinbase CEO Brian Armstrong, has secured a significant $130 million in funding through a Series B round. This investment from Kleiner Perkins will […]
NewLimit Secures $130 Million Series B Funding to Advance Anti-Aging Research
Biotechnology firm NewLimit has received a significant $130 million Series B funding round, led by the renowned venture capital firm Kleiner Perkins. This investment underscores the potential of […]